XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 6,981 $ 8,062
Accounts receivable (net of allowance for doubtful accounts of $78 in 2021 and $85 in 2020) 8,235 7,851
Inventories (excludes inventories of $2,175 in 2021 and $2,197 in 2020 classified in Other assets - see Note 6) 6,402 6,310
Other current assets 5,291 5,541
Total current assets 26,909 27,764
Investments 544 785
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,732 in 2021 and $18,982 in 2020 18,295 17,986
Goodwill 20,212 20,238
Other Intangibles, Net 14,401 14,604
Other Assets 10,486 10,211
Total Assets 90,847 91,588
Current Liabilities    
Loans payable and current portion of long-term debt 7,251 6,431
Trade accounts payable 4,034 4,594
Accrued and other current liabilities 11,911 13,053
Income taxes payable 1,490 1,575
Dividends payable 1,675 1,674
Total current liabilities 26,361 27,327
Long-Term Debt 24,002 25,360
Deferred Income Taxes 1,204 1,015
Other Noncurrent Liabilities 12,241 12,482
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020 1,788 1,788
Other paid-in capital 39,613 39,588
Retained earnings 48,888 47,362
Accumulated other comprehensive loss (6,622) (6,634)
Stockholders' equity before deduction for treasury stock 83,667 82,104
Less treasury stock, at cost: 1,045,799,775 shares in 2021 and 1,046,877,695 shares in 2020 56,722 56,787
Total Merck & Co., Inc. stockholders’ equity 26,945 25,317
Noncontrolling Interests 94 87
Total equity 27,039 25,404
Liabilities and Equity $ 90,847 $ 91,588